The benefit of pacemaker therapy in patients with neurally mediated syncope and documented asystole: A meta-analysis of implantable loop recorder studies

Michele Brignole, Jean Claude Deharo, Carlo Menozzi, Angel Moya, Richard Sutton, Marco Tomaino, Andrea Ungar

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Aim: Although the efficacy of cardiac pacing in patients with neurally mediated syncope (NMS) and documented asystole is established, a more robust point estimate of the benefit, which is not possible with any individual study, is lacking. Methods and results: We undertook a meta-analysis of individual participant data from four studies that reported follow-up data on syncope recurrence with cardiac pacing in patients with NMS who had had an electrocardiographic (ECG) documentation of an asystolic event by means of implantable loop recorder (ILR). Of a total of 1046 patients, who had ILR implanted, 383 (36.6%) patients had an ECG documentation of a diagnostic event during mean follow-up of 13± 10 months. Of these, 201 (52%) patients, corresponding to 19.2% of the total ILRs, had an asystolic event of 12.8± 11.0 s duration documented and met the criteria for pacemaker therapy. Follow-up was available in 121 (60%) of those patients with asystolic events. Syncope recurred after pacing in 18 (14.9%) patients with an actuarial rate of 13% [95% confidence interval (CI) ±6] at 1 year, 21% (95%CI ±10) at 2 years, and 24% (95%CI ±11) at 3 years. On multivariable Cox regression analysis, positive tilt test response was the only significant predictor of syncope recurrence with a hazard ratio (95% CI) of 4.3 (1.4-13). On the contrary, type of asystolic event (sinus arrest or atrioventricular block), prodrome, cardiac abnormalities, number and duration of history of syncope, age, and gender were not predictors of recurrence of syncope. Conclusion: A long asystolic pause, suitable for pacemaker therapy, was found in one of five patients with ILR. After pacemaker implantation, most of these patients remained free of syncope recurrence for up to 3 years. The benefit of pacemaker was greater in patients with negative tilt test.

Original languageEnglish
Pages (from-to)1362-1366
Number of pages5
JournalEuropace
Volume20
Issue number8
DOIs
Publication statusPublished - Jan 1 2018
Externally publishedYes

Fingerprint

Syncope
Heart Arrest
Meta-Analysis
Confidence Intervals
Therapeutics
Recurrence
Documentation
Atrioventricular Block
Regression Analysis

Keywords

  • Atrioventricular block
  • Cardiac pacing
  • Implantable loop recorder
  • Meta-analysis
  • Neurally mediated
  • Pacemaker
  • Reflex
  • Sinus arrest
  • Syncope

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

The benefit of pacemaker therapy in patients with neurally mediated syncope and documented asystole : A meta-analysis of implantable loop recorder studies. / Brignole, Michele; Deharo, Jean Claude; Menozzi, Carlo; Moya, Angel; Sutton, Richard; Tomaino, Marco; Ungar, Andrea.

In: Europace, Vol. 20, No. 8, 01.01.2018, p. 1362-1366.

Research output: Contribution to journalArticle

Brignole, Michele ; Deharo, Jean Claude ; Menozzi, Carlo ; Moya, Angel ; Sutton, Richard ; Tomaino, Marco ; Ungar, Andrea. / The benefit of pacemaker therapy in patients with neurally mediated syncope and documented asystole : A meta-analysis of implantable loop recorder studies. In: Europace. 2018 ; Vol. 20, No. 8. pp. 1362-1366.
@article{aedd682dd53442bc814064fe44e81ff6,
title = "The benefit of pacemaker therapy in patients with neurally mediated syncope and documented asystole: A meta-analysis of implantable loop recorder studies",
abstract = "Aim: Although the efficacy of cardiac pacing in patients with neurally mediated syncope (NMS) and documented asystole is established, a more robust point estimate of the benefit, which is not possible with any individual study, is lacking. Methods and results: We undertook a meta-analysis of individual participant data from four studies that reported follow-up data on syncope recurrence with cardiac pacing in patients with NMS who had had an electrocardiographic (ECG) documentation of an asystolic event by means of implantable loop recorder (ILR). Of a total of 1046 patients, who had ILR implanted, 383 (36.6{\%}) patients had an ECG documentation of a diagnostic event during mean follow-up of 13± 10 months. Of these, 201 (52{\%}) patients, corresponding to 19.2{\%} of the total ILRs, had an asystolic event of 12.8± 11.0 s duration documented and met the criteria for pacemaker therapy. Follow-up was available in 121 (60{\%}) of those patients with asystolic events. Syncope recurred after pacing in 18 (14.9{\%}) patients with an actuarial rate of 13{\%} [95{\%} confidence interval (CI) ±6] at 1 year, 21{\%} (95{\%}CI ±10) at 2 years, and 24{\%} (95{\%}CI ±11) at 3 years. On multivariable Cox regression analysis, positive tilt test response was the only significant predictor of syncope recurrence with a hazard ratio (95{\%} CI) of 4.3 (1.4-13). On the contrary, type of asystolic event (sinus arrest or atrioventricular block), prodrome, cardiac abnormalities, number and duration of history of syncope, age, and gender were not predictors of recurrence of syncope. Conclusion: A long asystolic pause, suitable for pacemaker therapy, was found in one of five patients with ILR. After pacemaker implantation, most of these patients remained free of syncope recurrence for up to 3 years. The benefit of pacemaker was greater in patients with negative tilt test.",
keywords = "Atrioventricular block, Cardiac pacing, Implantable loop recorder, Meta-analysis, Neurally mediated, Pacemaker, Reflex, Sinus arrest, Syncope",
author = "Michele Brignole and Deharo, {Jean Claude} and Carlo Menozzi and Angel Moya and Richard Sutton and Marco Tomaino and Andrea Ungar",
year = "2018",
month = "1",
day = "1",
doi = "10.1093/europace/eux321",
language = "English",
volume = "20",
pages = "1362--1366",
journal = "Europace",
issn = "1099-5129",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - The benefit of pacemaker therapy in patients with neurally mediated syncope and documented asystole

T2 - A meta-analysis of implantable loop recorder studies

AU - Brignole, Michele

AU - Deharo, Jean Claude

AU - Menozzi, Carlo

AU - Moya, Angel

AU - Sutton, Richard

AU - Tomaino, Marco

AU - Ungar, Andrea

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Aim: Although the efficacy of cardiac pacing in patients with neurally mediated syncope (NMS) and documented asystole is established, a more robust point estimate of the benefit, which is not possible with any individual study, is lacking. Methods and results: We undertook a meta-analysis of individual participant data from four studies that reported follow-up data on syncope recurrence with cardiac pacing in patients with NMS who had had an electrocardiographic (ECG) documentation of an asystolic event by means of implantable loop recorder (ILR). Of a total of 1046 patients, who had ILR implanted, 383 (36.6%) patients had an ECG documentation of a diagnostic event during mean follow-up of 13± 10 months. Of these, 201 (52%) patients, corresponding to 19.2% of the total ILRs, had an asystolic event of 12.8± 11.0 s duration documented and met the criteria for pacemaker therapy. Follow-up was available in 121 (60%) of those patients with asystolic events. Syncope recurred after pacing in 18 (14.9%) patients with an actuarial rate of 13% [95% confidence interval (CI) ±6] at 1 year, 21% (95%CI ±10) at 2 years, and 24% (95%CI ±11) at 3 years. On multivariable Cox regression analysis, positive tilt test response was the only significant predictor of syncope recurrence with a hazard ratio (95% CI) of 4.3 (1.4-13). On the contrary, type of asystolic event (sinus arrest or atrioventricular block), prodrome, cardiac abnormalities, number and duration of history of syncope, age, and gender were not predictors of recurrence of syncope. Conclusion: A long asystolic pause, suitable for pacemaker therapy, was found in one of five patients with ILR. After pacemaker implantation, most of these patients remained free of syncope recurrence for up to 3 years. The benefit of pacemaker was greater in patients with negative tilt test.

AB - Aim: Although the efficacy of cardiac pacing in patients with neurally mediated syncope (NMS) and documented asystole is established, a more robust point estimate of the benefit, which is not possible with any individual study, is lacking. Methods and results: We undertook a meta-analysis of individual participant data from four studies that reported follow-up data on syncope recurrence with cardiac pacing in patients with NMS who had had an electrocardiographic (ECG) documentation of an asystolic event by means of implantable loop recorder (ILR). Of a total of 1046 patients, who had ILR implanted, 383 (36.6%) patients had an ECG documentation of a diagnostic event during mean follow-up of 13± 10 months. Of these, 201 (52%) patients, corresponding to 19.2% of the total ILRs, had an asystolic event of 12.8± 11.0 s duration documented and met the criteria for pacemaker therapy. Follow-up was available in 121 (60%) of those patients with asystolic events. Syncope recurred after pacing in 18 (14.9%) patients with an actuarial rate of 13% [95% confidence interval (CI) ±6] at 1 year, 21% (95%CI ±10) at 2 years, and 24% (95%CI ±11) at 3 years. On multivariable Cox regression analysis, positive tilt test response was the only significant predictor of syncope recurrence with a hazard ratio (95% CI) of 4.3 (1.4-13). On the contrary, type of asystolic event (sinus arrest or atrioventricular block), prodrome, cardiac abnormalities, number and duration of history of syncope, age, and gender were not predictors of recurrence of syncope. Conclusion: A long asystolic pause, suitable for pacemaker therapy, was found in one of five patients with ILR. After pacemaker implantation, most of these patients remained free of syncope recurrence for up to 3 years. The benefit of pacemaker was greater in patients with negative tilt test.

KW - Atrioventricular block

KW - Cardiac pacing

KW - Implantable loop recorder

KW - Meta-analysis

KW - Neurally mediated

KW - Pacemaker

KW - Reflex

KW - Sinus arrest

KW - Syncope

UR - http://www.scopus.com/inward/record.url?scp=85049491397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049491397&partnerID=8YFLogxK

U2 - 10.1093/europace/eux321

DO - 10.1093/europace/eux321

M3 - Article

AN - SCOPUS:85049491397

VL - 20

SP - 1362

EP - 1366

JO - Europace

JF - Europace

SN - 1099-5129

IS - 8

ER -